Literature DB >> 7261486

The use of propranolol and nifedipine in the medical management of angina pectoris.

K M Fox, A Jonathan, A P Selwyn.   

Abstract

This study investigates the use of propranolol and nifedipine in the treatment of angina pectoris. The clinical response and the effects on the precordial 16-lead electrocardiogram before and after exercise were studied in 52 patients with frequent angina pectoris. Relief of chest pain and abolition of exercise-induced ST-segment depression was achieved in 16 patients on treatment with propranolol alone (mean dose, 300 mg/d). Of the remaining 36 patients, the precordial area and severity of exercise-induced ST-segment depression were unchanged in 8 patients, of whom 2 reported they were free from chest pain, improved in 10 patients of whom 4 reported they were free of chest pain, and abolished in 14 patients, all of whom were free from chest pain following treatment with both propranolol and nifedipine (mean dose, 50 mg/d). Four patients were unable to tolerate this combination. This study has shown that in patients who do not respond to treatment with propranolol alone the combination of propranolol and nifedipine can be used to control not only anginal pain, but also the precordial electrocardiographic manifestations of ischemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261486     DOI: 10.1002/clc.4960040303

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

Review 1.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 2.  Profile of an ideal antianginal agent.

Authors:  E J Lazar; W H Frishman
Journal:  Drugs       Date:  1989       Impact factor: 9.546

3.  Changes in haemodynamics and left ventricular function during intravenous nifedipine infusion with and without additional propranolol in patients with coronary artery disease. A randomized, placebo controlled trial.

Authors:  M Mauser; W Voelker; D Roser; K R Karsch; L Seipel
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Slow release nifedipine plus atenolol in chronic stable angina pectoris.

Authors:  V F Challenor; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

5.  Heart insufficiency after combination of verapamil and metoprolol: A fatal case report and literature review.

Authors:  Eva A Saedder; Asser Hedegård Thomsen; Jørgen Bo Hasselstrøm; Jakob Ross Jornil
Journal:  Clin Case Rep       Date:  2019-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.